nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—psoriasis—atopic dermatitis	0.424	1	CtDrD
Cyclosporine—PPP3CA—Tacrolimus—atopic dermatitis	0.152	0.352	CbGbCtD
Cyclosporine—FKBP1A—Pimecrolimus—atopic dermatitis	0.106	0.246	CbGbCtD
Cyclosporine—FKBP1A—Tacrolimus—atopic dermatitis	0.0632	0.146	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.00613	0.0141	CbGbCtD
Cyclosporine—CYP3A7—Tacrolimus—atopic dermatitis	0.00613	0.0141	CbGbCtD
Cyclosporine—CYP2C8—Mometasone—atopic dermatitis	0.00563	0.013	CbGbCtD
Cyclosporine—SLCO1A2—Prednisolone—atopic dermatitis	0.00475	0.011	CbGbCtD
Cyclosporine—CYP3A5—Tacrolimus—atopic dermatitis	0.0046	0.0106	CbGbCtD
Cyclosporine—SLCO1A2—Hydrocortisone—atopic dermatitis	0.00451	0.0104	CbGbCtD
Cyclosporine—SLCO1A2—Prednisone—atopic dermatitis	0.00449	0.0104	CbGbCtD
Cyclosporine—ABCB11—Dexamethasone—atopic dermatitis	0.00442	0.0102	CbGbCtD
Cyclosporine—ABCG2—Hydrocortisone—atopic dermatitis	0.00338	0.0078	CbGbCtD
Cyclosporine—CYP2C8—Loratadine—atopic dermatitis	0.00323	0.00747	CbGbCtD
Cyclosporine—CYP3A4—Pimecrolimus—atopic dermatitis	0.00301	0.00696	CbGbCtD
Cyclosporine—ABCB1—Tacrolimus—atopic dermatitis	0.00299	0.00691	CbGbCtD
Cyclosporine—SLCO1A2—Dexamethasone—atopic dermatitis	0.0028	0.00647	CbGbCtD
Cyclosporine—CYP2C19—Loratadine—atopic dermatitis	0.00271	0.00627	CbGbCtD
Cyclosporine—CYP2C19—Diphenhydramine—atopic dermatitis	0.00271	0.00627	CbGbCtD
Cyclosporine—CYP3A7—Hydrocortisone—atopic dermatitis	0.00249	0.00576	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00249	0.00576	CbGbCtD
Cyclosporine—ABCC2—Dexamethasone—atopic dermatitis	0.00232	0.00537	CbGbCtD
Cyclosporine—CYP2C9—Loratadine—atopic dermatitis	0.00226	0.00521	CbGbCtD
Cyclosporine—CYP2C9—Diphenhydramine—atopic dermatitis	0.00226	0.00521	CbGbCtD
Cyclosporine—ABCB1—Loratadine—atopic dermatitis	0.00219	0.00506	CbGbCtD
Cyclosporine—ABCG2—Dexamethasone—atopic dermatitis	0.0021	0.00485	CbGbCtD
Cyclosporine—CYP2D6—Loratadine—atopic dermatitis	0.00206	0.00476	CbGbCtD
Cyclosporine—CYP2D6—Diphenhydramine—atopic dermatitis	0.00206	0.00476	CbGbCtD
Cyclosporine—ABCB1—Methylprednisolone—atopic dermatitis	0.002	0.00462	CbGbCtD
Cyclosporine—CYP3A5—Hydrocortisone—atopic dermatitis	0.00187	0.00432	CbGbCtD
Cyclosporine—CYP2C8—Hydrocortisone—atopic dermatitis	0.0018	0.00415	CbGbCtD
Cyclosporine—CYP3A4—Tacrolimus—atopic dermatitis	0.00179	0.00414	CbGbCtD
Cyclosporine—CYP3A7—Dexamethasone—atopic dermatitis	0.00155	0.00358	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00155	0.00358	CbGbCtD
Cyclosporine—CYP2C19—Prednisone—atopic dermatitis	0.0015	0.00347	CbGbCtD
Cyclosporine—CYP3A4—Loratadine—atopic dermatitis	0.00131	0.00303	CbGbCtD
Cyclosporine—ABCB1—Betamethasone—atopic dermatitis	0.0013	0.00301	CbGbCtD
Cyclosporine—ABCB1—Prednisolone—atopic dermatitis	0.00128	0.00297	CbGbCtD
Cyclosporine—ABCB1—Hydrocortisone—atopic dermatitis	0.00122	0.00281	CbGbCtD
Cyclosporine—ABCB1—Prednisone—atopic dermatitis	0.00121	0.0028	CbGbCtD
Cyclosporine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0012	0.00277	CbGbCtD
Cyclosporine—CYP3A5—Dexamethasone—atopic dermatitis	0.00116	0.00269	CbGbCtD
Cyclosporine—CYP2C8—Dexamethasone—atopic dermatitis	0.00112	0.00258	CbGbCtD
Cyclosporine—CYP2C19—Dexamethasone—atopic dermatitis	0.000939	0.00217	CbGbCtD
Cyclosporine—CYP3A4—Triamcinolone—atopic dermatitis	0.000909	0.0021	CbGbCtD
Cyclosporine—CYP2C9—Dexamethasone—atopic dermatitis	0.000781	0.0018	CbGbCtD
Cyclosporine—CYP3A4—Betamethasone—atopic dermatitis	0.00078	0.0018	CbGbCtD
Cyclosporine—CYP3A4—Prednisolone—atopic dermatitis	0.00077	0.00178	CbGbCtD
Cyclosporine—ABCB1—Dexamethasone—atopic dermatitis	0.000757	0.00175	CbGbCtD
Cyclosporine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00073	0.00169	CbGbCtD
Cyclosporine—CYP3A4—Prednisone—atopic dermatitis	0.000727	0.00168	CbGbCtD
Cyclosporine—CYP2D6—Dexamethasone—atopic dermatitis	0.000714	0.00165	CbGbCtD
Cyclosporine—FKBP4—skin of body—atopic dermatitis	0.000604	0.103	CbGeAlD
Cyclosporine—PPIB—neck—atopic dermatitis	0.000596	0.102	CbGeAlD
Cyclosporine—FKBP1B—head—atopic dermatitis	0.000596	0.102	CbGeAlD
Cyclosporine—PPIF—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000542	0.25	CbGdCrCtD
Cyclosporine—PPIF—Sirolimus—Pimecrolimus—atopic dermatitis	0.000542	0.25	CbGdCrCtD
Cyclosporine—PPIF—Sirolimus—Tacrolimus—atopic dermatitis	0.000542	0.25	CbGdCrCtD
Cyclosporine—PPIF—Temsirolimus—Tacrolimus—atopic dermatitis	0.000542	0.25	CbGdCrCtD
Cyclosporine—CYP3A4—Dexamethasone—atopic dermatitis	0.000454	0.00105	CbGbCtD
Cyclosporine—PPIF—skin of body—atopic dermatitis	0.000405	0.0692	CbGeAlD
Cyclosporine—FKBP1A—neck—atopic dermatitis	0.000398	0.068	CbGeAlD
Cyclosporine—FKBP4—head—atopic dermatitis	0.000394	0.0673	CbGeAlD
Cyclosporine—PPIB—skin of body—atopic dermatitis	0.000386	0.0659	CbGeAlD
Cyclosporine—PPID—head—atopic dermatitis	0.000364	0.0621	CbGeAlD
Cyclosporine—CAMLG—head—atopic dermatitis	0.000358	0.0612	CbGeAlD
Cyclosporine—PPIF—head—atopic dermatitis	0.000264	0.0452	CbGeAlD
Cyclosporine—FKBP1A—skin of body—atopic dermatitis	0.000258	0.044	CbGeAlD
Cyclosporine—PPP3CA—head—atopic dermatitis	0.000253	0.0432	CbGeAlD
Cyclosporine—PPIB—head—atopic dermatitis	0.000252	0.043	CbGeAlD
Cyclosporine—SLC10A1—head—atopic dermatitis	0.000215	0.0368	CbGeAlD
Cyclosporine—FKBP1A—head—atopic dermatitis	0.000168	0.0287	CbGeAlD
Cyclosporine—ABCC3—head—atopic dermatitis	0.000135	0.0231	CbGeAlD
Cyclosporine—SLCO1A2—head—atopic dermatitis	0.000116	0.0198	CbGeAlD
Cyclosporine—PPP3CA—Immune System—FCER1A—atopic dermatitis	5.76e-05	0.00191	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	5.76e-05	0.00191	CbGpPWpGaD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—TNF—atopic dermatitis	5.75e-05	0.00191	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—CXCL8—atopic dermatitis	5.7e-05	0.00189	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.66e-05	0.00188	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—STAT6—atopic dermatitis	5.57e-05	0.00185	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.48e-05	0.00182	CbGpPWpGaD
Cyclosporine—PPP3CA—Alzheimers Disease—TNF—atopic dermatitis	5.47e-05	0.00181	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL1B—atopic dermatitis	5.47e-05	0.00181	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL2—atopic dermatitis	5.45e-05	0.00181	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—CASP8—atopic dermatitis	5.43e-05	0.0018	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CARD11—atopic dermatitis	5.42e-05	0.0018	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.42e-05	0.0018	CbGpPWpGaD
Cyclosporine—CYP2D6—head—atopic dermatitis	5.41e-05	0.00924	CbGeAlD
Cyclosporine—PPP3CA—Immune System—MS4A2—atopic dermatitis	5.36e-05	0.00178	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—IL5—atopic dermatitis	5.35e-05	0.00178	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL27—atopic dermatitis	5.23e-05	0.00173	CbGpPWpGaD
Cyclosporine—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	5.21e-05	0.00173	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.15e-05	0.00171	CbGpPWpGaD
Cyclosporine—PPIA—Disease—GLB1—atopic dermatitis	5.06e-05	0.00168	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	5.04e-05	0.00167	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—GLB1—atopic dermatitis	4.87e-05	0.00162	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—DEFB1—atopic dermatitis	4.77e-05	0.00158	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	4.77e-05	0.00158	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IFNG—atopic dermatitis	4.75e-05	0.00158	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL17—atopic dermatitis	4.69e-05	0.00156	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—ADSL—atopic dermatitis	4.67e-05	0.00155	CbGpPWpGaD
Cyclosporine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.59e-05	0.00152	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—CXCL8—atopic dermatitis	4.42e-05	0.00147	CbGpPWpGaD
Cyclosporine—PPIA—HIV Infection—CD4—atopic dermatitis	4.39e-05	0.00146	CbGpPWpGaD
Cyclosporine—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	4.35e-05	0.00144	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL13—atopic dermatitis	4.31e-05	0.00143	CbGpPWpGaD
Cyclosporine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.29e-05	0.00142	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL1B—atopic dermatitis	4.24e-05	0.00141	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CASP1—atopic dermatitis	4.22e-05	0.0014	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL2—atopic dermatitis	4.22e-05	0.0014	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.21e-05	0.0014	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—GLB1—atopic dermatitis	4.21e-05	0.0014	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.15e-05	0.00138	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—IL1B—atopic dermatitis	4.12e-05	0.00137	CbGpPWpGaD
Cyclosporine—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	4.09e-05	0.00136	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.98e-05	0.00132	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	3.97e-05	0.00132	CbGpPWpGaD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	3.97e-05	0.00132	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—TNF—atopic dermatitis	3.97e-05	0.00132	CbGpPWpGaD
Cyclosporine—ABCB1—head—atopic dermatitis	3.89e-05	0.00664	CbGeAlD
Cyclosporine—PPP3CA—Innate Immune System—TLR2—atopic dermatitis	3.82e-05	0.00127	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KIF3A—atopic dermatitis	3.82e-05	0.00127	CbGpPWpGaD
Cyclosporine—FKBP4—Cellular responses to stress—IL6—atopic dermatitis	3.81e-05	0.00126	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.8e-05	0.00126	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL11—atopic dermatitis	3.78e-05	0.00125	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—MAPK8—atopic dermatitis	3.78e-05	0.00125	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—FCER2—atopic dermatitis	3.73e-05	0.00124	CbGpPWpGaD
Cyclosporine—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	3.72e-05	0.00123	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL5—atopic dermatitis	3.69e-05	0.00122	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	3.62e-05	0.0012	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.55e-05	0.00118	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.47e-05	0.00115	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL22—atopic dermatitis	3.46e-05	0.00115	CbGpPWpGaD
Cyclosporine—PPIA—Disease—SLC11A1—atopic dermatitis	3.39e-05	0.00112	CbGpPWpGaD
Cyclosporine—SLC10A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.38e-05	0.00112	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—GLB1—atopic dermatitis	3.26e-05	0.00108	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—STAT6—atopic dermatitis	3.25e-05	0.00108	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL6—atopic dermatitis	3.2e-05	0.00106	CbGpPWpGaD
Cyclosporine—ABCC10—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.17e-05	0.00105	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CARD11—atopic dermatitis	3.16e-05	0.00105	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—GLB1—atopic dermatitis	3.14e-05	0.00104	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.12e-05	0.00104	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL27—atopic dermatitis	3.09e-05	0.00102	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CCR3—atopic dermatitis	3.08e-05	0.00102	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—TNF—atopic dermatitis	3.08e-05	0.00102	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—ADSL—atopic dermatitis	3.01e-05	0.000999	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—TNF—atopic dermatitis	2.99e-05	0.000992	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.97e-05	0.000984	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FCER2—atopic dermatitis	2.89e-05	0.000959	CbGpPWpGaD
Cyclosporine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.83e-05	0.000938	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—SLC11A1—atopic dermatitis	2.82e-05	0.000935	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL17—atopic dermatitis	2.77e-05	0.000919	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—NPS—atopic dermatitis	2.75e-05	0.000911	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—TAC1—atopic dermatitis	2.75e-05	0.000911	CbGpPWpGaD
Cyclosporine—Hypertension—Hydrocortisone—atopic dermatitis	2.72e-05	0.00026	CcSEcCtD
Cyclosporine—Discomfort—Prednisolone—atopic dermatitis	2.71e-05	0.000259	CcSEcCtD
Cyclosporine—Angioedema—Triamcinolone—atopic dermatitis	2.71e-05	0.000259	CcSEcCtD
Cyclosporine—Haemoglobin—Prednisone—atopic dermatitis	2.7e-05	0.000258	CcSEcCtD
Cyclosporine—Angioedema—Methylprednisolone—atopic dermatitis	2.7e-05	0.000258	CcSEcCtD
Cyclosporine—ABCB1—Allograft Rejection—IL10—atopic dermatitis	2.7e-05	0.000895	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CXCR3—atopic dermatitis	2.69e-05	0.000893	CbGpPWpGaD
Cyclosporine—Haemorrhage—Prednisone—atopic dermatitis	2.69e-05	0.000257	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—CCL22—atopic dermatitis	2.69e-05	0.000891	CbGpPWpGaD
Cyclosporine—Myalgia—Hydrocortisone—atopic dermatitis	2.68e-05	0.000256	CcSEcCtD
Cyclosporine—Malaise—Triamcinolone—atopic dermatitis	2.67e-05	0.000255	CcSEcCtD
Cyclosporine—Anxiety—Hydrocortisone—atopic dermatitis	2.67e-05	0.000255	CcSEcCtD
Cyclosporine—Malaise—Methylprednisolone—atopic dermatitis	2.67e-05	0.000255	CcSEcCtD
Cyclosporine—Vertigo—Triamcinolone—atopic dermatitis	2.66e-05	0.000254	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	2.66e-05	0.000254	CcSEcCtD
Cyclosporine—Vertigo—Methylprednisolone—atopic dermatitis	2.66e-05	0.000254	CcSEcCtD
Cyclosporine—Discomfort—Hydrocortisone—atopic dermatitis	2.65e-05	0.000253	CcSEcCtD
Cyclosporine—Connective tissue disorder—Prednisone—atopic dermatitis	2.64e-05	0.000253	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.64e-05	0.000877	CbGpPWpGaD
Cyclosporine—Anaphylactic shock—Prednisolone—atopic dermatitis	2.63e-05	0.000251	CcSEcCtD
Cyclosporine—Oedema—Prednisolone—atopic dermatitis	2.63e-05	0.000251	CcSEcCtD
Cyclosporine—ABCB1—Allograft Rejection—IL4—atopic dermatitis	2.62e-05	0.000871	CbGpPWpGaD
Cyclosporine—Vomiting—Tacrolimus—atopic dermatitis	2.62e-05	0.00025	CcSEcCtD
Cyclosporine—Rash—Tacrolimus—atopic dermatitis	2.6e-05	0.000248	CcSEcCtD
Cyclosporine—Dermatitis—Tacrolimus—atopic dermatitis	2.59e-05	0.000248	CcSEcCtD
Cyclosporine—Cough—Triamcinolone—atopic dermatitis	2.59e-05	0.000247	CcSEcCtD
Cyclosporine—Headache—Tacrolimus—atopic dermatitis	2.58e-05	0.000246	CcSEcCtD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.58e-05	0.000855	CbGpPWpGaD
Cyclosporine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	2.57e-05	0.000245	CcSEcCtD
Cyclosporine—Oedema—Hydrocortisone—atopic dermatitis	2.57e-05	0.000245	CcSEcCtD
Cyclosporine—Convulsion—Triamcinolone—atopic dermatitis	2.57e-05	0.000245	CcSEcCtD
Cyclosporine—Convulsion—Methylprednisolone—atopic dermatitis	2.56e-05	0.000245	CcSEcCtD
Cyclosporine—Hypertension—Triamcinolone—atopic dermatitis	2.56e-05	0.000244	CcSEcCtD
Cyclosporine—Hypertension—Methylprednisolone—atopic dermatitis	2.55e-05	0.000244	CcSEcCtD
Cyclosporine—Infection—Hydrocortisone—atopic dermatitis	2.55e-05	0.000244	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—IL5—atopic dermatitis	2.55e-05	0.000847	CbGpPWpGaD
Cyclosporine—Hyperhidrosis—Prednisolone—atopic dermatitis	2.54e-05	0.000243	CcSEcCtD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.54e-05	0.000842	CbGpPWpGaD
Cyclosporine—Myalgia—Triamcinolone—atopic dermatitis	2.52e-05	0.000241	CcSEcCtD
Cyclosporine—Nervous system disorder—Hydrocortisone—atopic dermatitis	2.52e-05	0.000241	CcSEcCtD
Cyclosporine—Arthralgia—Methylprednisolone—atopic dermatitis	2.52e-05	0.00024	CcSEcCtD
Cyclosporine—Myalgia—Methylprednisolone—atopic dermatitis	2.52e-05	0.00024	CcSEcCtD
Cyclosporine—Anxiety—Methylprednisolone—atopic dermatitis	2.51e-05	0.00024	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	2.5e-05	0.000239	CcSEcCtD
Cyclosporine—Flushing—Prednisone—atopic dermatitis	2.5e-05	0.000238	CcSEcCtD
Cyclosporine—Skin disorder—Hydrocortisone—atopic dermatitis	2.5e-05	0.000238	CcSEcCtD
Cyclosporine—Ill-defined disorder—Dexamethasone—atopic dermatitis	2.5e-05	0.000238	CcSEcCtD
Cyclosporine—Ill-defined disorder—Betamethasone—atopic dermatitis	2.5e-05	0.000238	CcSEcCtD
Cyclosporine—Discomfort—Triamcinolone—atopic dermatitis	2.49e-05	0.000238	CcSEcCtD
Cyclosporine—Discomfort—Methylprednisolone—atopic dermatitis	2.49e-05	0.000238	CcSEcCtD
Cyclosporine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	2.48e-05	0.000237	CcSEcCtD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL6—atopic dermatitis	2.48e-05	0.000823	CbGpPWpGaD
Cyclosporine—Dry mouth—Triamcinolone—atopic dermatitis	2.47e-05	0.000236	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—KIF3A—atopic dermatitis	2.47e-05	0.000819	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CASP1—atopic dermatitis	2.46e-05	0.000816	CbGpPWpGaD
Cyclosporine—Angioedema—Betamethasone—atopic dermatitis	2.46e-05	0.000235	CcSEcCtD
Cyclosporine—Angioedema—Dexamethasone—atopic dermatitis	2.46e-05	0.000235	CcSEcCtD
Cyclosporine—Anorexia—Hydrocortisone—atopic dermatitis	2.45e-05	0.000234	CcSEcCtD
Cyclosporine—Nausea—Tacrolimus—atopic dermatitis	2.45e-05	0.000234	CcSEcCtD
Cyclosporine—Angiopathy—Prednisone—atopic dermatitis	2.44e-05	0.000233	CcSEcCtD
Cyclosporine—Confusional state—Methylprednisolone—atopic dermatitis	2.43e-05	0.000232	CcSEcCtD
Cyclosporine—Malaise—Dexamethasone—atopic dermatitis	2.43e-05	0.000232	CcSEcCtD
Cyclosporine—Malaise—Betamethasone—atopic dermatitis	2.43e-05	0.000232	CcSEcCtD
Cyclosporine—Oedema—Triamcinolone—atopic dermatitis	2.42e-05	0.000231	CcSEcCtD
Cyclosporine—Anaphylactic shock—Triamcinolone—atopic dermatitis	2.42e-05	0.000231	CcSEcCtD
Cyclosporine—Vertigo—Betamethasone—atopic dermatitis	2.42e-05	0.000231	CcSEcCtD
Cyclosporine—Vertigo—Dexamethasone—atopic dermatitis	2.42e-05	0.000231	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	2.41e-05	0.000231	CcSEcCtD
Cyclosporine—Arrhythmia—Prednisone—atopic dermatitis	2.4e-05	0.00023	CcSEcCtD
Cyclosporine—Infection—Triamcinolone—atopic dermatitis	2.4e-05	0.00023	CcSEcCtD
Cyclosporine—Infection—Methylprednisolone—atopic dermatitis	2.4e-05	0.000229	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—CCL27—atopic dermatitis	2.39e-05	0.000794	CbGpPWpGaD
Cyclosporine—Insomnia—Prednisolone—atopic dermatitis	2.38e-05	0.000227	CcSEcCtD
Cyclosporine—Alopecia—Prednisone—atopic dermatitis	2.38e-05	0.000227	CcSEcCtD
Cyclosporine—Nervous system disorder—Methylprednisolone—atopic dermatitis	2.37e-05	0.000226	CcSEcCtD
Cyclosporine—Paraesthesia—Prednisolone—atopic dermatitis	2.36e-05	0.000226	CcSEcCtD
Cyclosporine—Mental disorder—Prednisone—atopic dermatitis	2.36e-05	0.000225	CcSEcCtD
Cyclosporine—Skin disorder—Methylprednisolone—atopic dermatitis	2.34e-05	0.000224	CcSEcCtD
Cyclosporine—Malnutrition—Prednisone—atopic dermatitis	2.34e-05	0.000224	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	2.34e-05	0.000224	CcSEcCtD
Cyclosporine—Hyperhidrosis—Triamcinolone—atopic dermatitis	2.34e-05	0.000223	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	2.33e-05	0.000223	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—IL5—atopic dermatitis	2.33e-05	0.000774	CbGpPWpGaD
Cyclosporine—Convulsion—Betamethasone—atopic dermatitis	2.33e-05	0.000223	CcSEcCtD
Cyclosporine—Convulsion—Dexamethasone—atopic dermatitis	2.33e-05	0.000223	CcSEcCtD
Cyclosporine—Insomnia—Hydrocortisone—atopic dermatitis	2.32e-05	0.000222	CcSEcCtD
Cyclosporine—Hypertension—Dexamethasone—atopic dermatitis	2.32e-05	0.000222	CcSEcCtD
Cyclosporine—Hypertension—Betamethasone—atopic dermatitis	2.32e-05	0.000222	CcSEcCtD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.31e-05	0.000768	CbGpPWpGaD
Cyclosporine—Paraesthesia—Hydrocortisone—atopic dermatitis	2.31e-05	0.00022	CcSEcCtD
Cyclosporine—Myalgia—Betamethasone—atopic dermatitis	2.29e-05	0.000219	CcSEcCtD
Cyclosporine—Myalgia—Dexamethasone—atopic dermatitis	2.29e-05	0.000219	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.29e-05	0.000759	CbGpPWpGaD
Cyclosporine—Anxiety—Dexamethasone—atopic dermatitis	2.28e-05	0.000218	CcSEcCtD
Cyclosporine—Anxiety—Betamethasone—atopic dermatitis	2.28e-05	0.000218	CcSEcCtD
Cyclosporine—Discomfort—Dexamethasone—atopic dermatitis	2.26e-05	0.000216	CcSEcCtD
Cyclosporine—Discomfort—Betamethasone—atopic dermatitis	2.26e-05	0.000216	CcSEcCtD
Cyclosporine—Dyspepsia—Hydrocortisone—atopic dermatitis	2.26e-05	0.000216	CcSEcCtD
Cyclosporine—Pain—Prednisolone—atopic dermatitis	2.25e-05	0.000215	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—NFKBIA—atopic dermatitis	2.24e-05	0.000745	CbGpPWpGaD
Cyclosporine—Decreased appetite—Hydrocortisone—atopic dermatitis	2.23e-05	0.000213	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—CCL11—atopic dermatitis	2.23e-05	0.000741	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CMA1—atopic dermatitis	2.23e-05	0.000741	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—TLR2—atopic dermatitis	2.22e-05	0.000738	CbGpPWpGaD
Cyclosporine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	2.22e-05	0.000212	CcSEcCtD
Cyclosporine—Fatigue—Hydrocortisone—atopic dermatitis	2.22e-05	0.000212	CcSEcCtD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.21e-05	0.000733	CbGpPWpGaD
Cyclosporine—Vision blurred—Prednisone—atopic dermatitis	2.21e-05	0.000211	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Cyclosporine—Pain—Hydrocortisone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Cyclosporine—Oedema—Betamethasone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Cyclosporine—Anaphylactic shock—Betamethasone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Cyclosporine—Oedema—Dexamethasone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Cyclosporine—Anaphylactic shock—Dexamethasone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Cyclosporine—Insomnia—Triamcinolone—atopic dermatitis	2.19e-05	0.000209	CcSEcCtD
Cyclosporine—FKBP1A—Disease—SLC11A1—atopic dermatitis	2.18e-05	0.000725	CbGpPWpGaD
Cyclosporine—Insomnia—Methylprednisolone—atopic dermatitis	2.18e-05	0.000209	CcSEcCtD
Cyclosporine—Infection—Betamethasone—atopic dermatitis	2.18e-05	0.000208	CcSEcCtD
Cyclosporine—Infection—Dexamethasone—atopic dermatitis	2.18e-05	0.000208	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CXCL10—atopic dermatitis	2.18e-05	0.000722	CbGpPWpGaD
Cyclosporine—Ill-defined disorder—Prednisone—atopic dermatitis	2.17e-05	0.000208	CcSEcCtD
Cyclosporine—Paraesthesia—Triamcinolone—atopic dermatitis	2.17e-05	0.000207	CcSEcCtD
Cyclosporine—Feeling abnormal—Prednisolone—atopic dermatitis	2.17e-05	0.000207	CcSEcCtD
Cyclosporine—Paraesthesia—Methylprednisolone—atopic dermatitis	2.17e-05	0.000207	CcSEcCtD
Cyclosporine—Anaemia—Prednisone—atopic dermatitis	2.16e-05	0.000207	CcSEcCtD
Cyclosporine—Dyspnoea—Triamcinolone—atopic dermatitis	2.16e-05	0.000206	CcSEcCtD
Cyclosporine—Nervous system disorder—Dexamethasone—atopic dermatitis	2.15e-05	0.000206	CcSEcCtD
Cyclosporine—Nervous system disorder—Betamethasone—atopic dermatitis	2.15e-05	0.000206	CcSEcCtD
Cyclosporine—Agitation—Prednisone—atopic dermatitis	2.15e-05	0.000206	CcSEcCtD
Cyclosporine—Thrombocytopenia—Betamethasone—atopic dermatitis	2.15e-05	0.000205	CcSEcCtD
Cyclosporine—Thrombocytopenia—Dexamethasone—atopic dermatitis	2.15e-05	0.000205	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—CCL17—atopic dermatitis	2.15e-05	0.000712	CbGpPWpGaD
Cyclosporine—Angioedema—Prednisone—atopic dermatitis	2.14e-05	0.000204	CcSEcCtD
Cyclosporine—Dyspepsia—Triamcinolone—atopic dermatitis	2.13e-05	0.000203	CcSEcCtD
Cyclosporine—Dyspepsia—Methylprednisolone—atopic dermatitis	2.12e-05	0.000203	CcSEcCtD
Cyclosporine—Hyperhidrosis—Betamethasone—atopic dermatitis	2.12e-05	0.000203	CcSEcCtD
Cyclosporine—Hyperhidrosis—Dexamethasone—atopic dermatitis	2.12e-05	0.000203	CcSEcCtD
Cyclosporine—Feeling abnormal—Hydrocortisone—atopic dermatitis	2.12e-05	0.000202	CcSEcCtD
Cyclosporine—Malaise—Prednisone—atopic dermatitis	2.11e-05	0.000202	CcSEcCtD
Cyclosporine—Vertigo—Prednisone—atopic dermatitis	2.1e-05	0.000201	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	2.1e-05	0.000201	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—STAT6—atopic dermatitis	2.1e-05	0.000696	CbGpPWpGaD
Cyclosporine—Anorexia—Dexamethasone—atopic dermatitis	2.09e-05	0.0002	CcSEcCtD
Cyclosporine—Anorexia—Betamethasone—atopic dermatitis	2.09e-05	0.0002	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.09e-05	0.000694	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD79A—atopic dermatitis	2.09e-05	0.000694	CbGpPWpGaD
Cyclosporine—Urticaria—Prednisolone—atopic dermatitis	2.09e-05	0.0002	CcSEcCtD
Cyclosporine—Fatigue—Triamcinolone—atopic dermatitis	2.09e-05	0.000199	CcSEcCtD
Cyclosporine—Fatigue—Methylprednisolone—atopic dermatitis	2.08e-05	0.000199	CcSEcCtD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.08e-05	0.000689	CbGpPWpGaD
Cyclosporine—Pain—Triamcinolone—atopic dermatitis	2.07e-05	0.000198	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—IL2—atopic dermatitis	2.04e-05	0.000678	CbGpPWpGaD
Cyclosporine—Urticaria—Hydrocortisone—atopic dermatitis	2.04e-05	0.000195	CcSEcCtD
Cyclosporine—Body temperature increased—Hydrocortisone—atopic dermatitis	2.03e-05	0.000194	CcSEcCtD
Cyclosporine—Abdominal pain—Hydrocortisone—atopic dermatitis	2.03e-05	0.000194	CcSEcCtD
Cyclosporine—Convulsion—Prednisone—atopic dermatitis	2.03e-05	0.000194	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—CASP8—atopic dermatitis	2.02e-05	0.000672	CbGpPWpGaD
Cyclosporine—Hypertension—Prednisone—atopic dermatitis	2.02e-05	0.000193	CcSEcCtD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.01e-05	0.000667	CbGpPWpGaD
Cyclosporine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	2e-05	0.000191	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	2e-05	0.000191	CcSEcCtD
Cyclosporine—Arthralgia—Prednisone—atopic dermatitis	1.99e-05	0.00019	CcSEcCtD
Cyclosporine—Myalgia—Prednisone—atopic dermatitis	1.99e-05	0.00019	CcSEcCtD
Cyclosporine—Feeling abnormal—Triamcinolone—atopic dermatitis	1.99e-05	0.00019	CcSEcCtD
Cyclosporine—Feeling abnormal—Methylprednisolone—atopic dermatitis	1.99e-05	0.00019	CcSEcCtD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.99e-05	0.00066	CbGpPWpGaD
Cyclosporine—Anxiety—Prednisone—atopic dermatitis	1.99e-05	0.00019	CcSEcCtD
Cyclosporine—Insomnia—Betamethasone—atopic dermatitis	1.99e-05	0.00019	CcSEcCtD
Cyclosporine—Insomnia—Dexamethasone—atopic dermatitis	1.99e-05	0.00019	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	1.98e-05	0.000189	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	1.97e-05	0.000189	CcSEcCtD
Cyclosporine—Paraesthesia—Betamethasone—atopic dermatitis	1.97e-05	0.000188	CcSEcCtD
Cyclosporine—Paraesthesia—Dexamethasone—atopic dermatitis	1.97e-05	0.000188	CcSEcCtD
Cyclosporine—Discomfort—Prednisone—atopic dermatitis	1.97e-05	0.000188	CcSEcCtD
Cyclosporine—Hypersensitivity—Prednisolone—atopic dermatitis	1.94e-05	0.000185	CcSEcCtD
Cyclosporine—Dyspepsia—Betamethasone—atopic dermatitis	1.93e-05	0.000185	CcSEcCtD
Cyclosporine—Dyspepsia—Dexamethasone—atopic dermatitis	1.93e-05	0.000185	CcSEcCtD
Cyclosporine—Urticaria—Triamcinolone—atopic dermatitis	1.92e-05	0.000184	CcSEcCtD
Cyclosporine—Urticaria—Methylprednisolone—atopic dermatitis	1.92e-05	0.000183	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—KIF3A—atopic dermatitis	1.91e-05	0.000635	CbGpPWpGaD
Cyclosporine—Body temperature increased—Triamcinolone—atopic dermatitis	1.91e-05	0.000183	CcSEcCtD
Cyclosporine—Anaphylactic shock—Prednisone—atopic dermatitis	1.91e-05	0.000183	CcSEcCtD
Cyclosporine—Oedema—Prednisone—atopic dermatitis	1.91e-05	0.000183	CcSEcCtD
Cyclosporine—Abdominal pain—Methylprednisolone—atopic dermatitis	1.91e-05	0.000182	CcSEcCtD
Cyclosporine—Decreased appetite—Betamethasone—atopic dermatitis	1.91e-05	0.000182	CcSEcCtD
Cyclosporine—Decreased appetite—Dexamethasone—atopic dermatitis	1.91e-05	0.000182	CcSEcCtD
Cyclosporine—Infection—Prednisone—atopic dermatitis	1.9e-05	0.000181	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	1.9e-05	0.000181	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	1.9e-05	0.000181	CcSEcCtD
Cyclosporine—Hypersensitivity—Hydrocortisone—atopic dermatitis	1.89e-05	0.000181	CcSEcCtD
Cyclosporine—Fatigue—Betamethasone—atopic dermatitis	1.89e-05	0.000181	CcSEcCtD
Cyclosporine—Fatigue—Dexamethasone—atopic dermatitis	1.89e-05	0.000181	CcSEcCtD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.89e-05	0.000627	CbGpPWpGaD
Cyclosporine—Pain—Dexamethasone—atopic dermatitis	1.88e-05	0.000179	CcSEcCtD
Cyclosporine—Pain—Betamethasone—atopic dermatitis	1.88e-05	0.000179	CcSEcCtD
Cyclosporine—Nervous system disorder—Prednisone—atopic dermatitis	1.87e-05	0.000179	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL5—atopic dermatitis	1.87e-05	0.000622	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.87e-05	0.000619	CbGpPWpGaD
Cyclosporine—Skin disorder—Prednisone—atopic dermatitis	1.86e-05	0.000177	CcSEcCtD
Cyclosporine—ABCB11—Metabolism—GLB1—atopic dermatitis	1.85e-05	0.000614	CbGpPWpGaD
Cyclosporine—Hyperhidrosis—Prednisone—atopic dermatitis	1.85e-05	0.000176	CcSEcCtD
Cyclosporine—Asthenia—Hydrocortisone—atopic dermatitis	1.84e-05	0.000176	CcSEcCtD
Cyclosporine—Anorexia—Prednisone—atopic dermatitis	1.82e-05	0.000174	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—CCR3—atopic dermatitis	1.82e-05	0.000604	CbGpPWpGaD
Cyclosporine—Pruritus—Hydrocortisone—atopic dermatitis	1.82e-05	0.000174	CcSEcCtD
Cyclosporine—Feeling abnormal—Betamethasone—atopic dermatitis	1.81e-05	0.000173	CcSEcCtD
Cyclosporine—Feeling abnormal—Dexamethasone—atopic dermatitis	1.81e-05	0.000173	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	1.8e-05	0.000171	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Betamethasone—atopic dermatitis	1.8e-05	0.000171	CcSEcCtD
Cyclosporine—Hypersensitivity—Triamcinolone—atopic dermatitis	1.78e-05	0.00017	CcSEcCtD
Cyclosporine—Hypersensitivity—Methylprednisolone—atopic dermatitis	1.78e-05	0.00017	CcSEcCtD
Cyclosporine—ABCC3—Metabolism—GLB1—atopic dermatitis	1.77e-05	0.000589	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ADSL—atopic dermatitis	1.77e-05	0.000589	CbGpPWpGaD
Cyclosporine—Diarrhoea—Hydrocortisone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.75e-05	0.00058	CbGpPWpGaD
Cyclosporine—Urticaria—Dexamethasone—atopic dermatitis	1.74e-05	0.000167	CcSEcCtD
Cyclosporine—Urticaria—Betamethasone—atopic dermatitis	1.74e-05	0.000167	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Cyclosporine—Dizziness—Prednisolone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Cyclosporine—Asthenia—Triamcinolone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Cyclosporine—Body temperature increased—Betamethasone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Cyclosporine—Abdominal pain—Betamethasone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Cyclosporine—Abdominal pain—Dexamethasone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Cyclosporine—Body temperature increased—Dexamethasone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Cyclosporine—Asthenia—Methylprednisolone—atopic dermatitis	1.73e-05	0.000165	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—CMA1—atopic dermatitis	1.73e-05	0.000574	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL11—atopic dermatitis	1.73e-05	0.000574	CbGpPWpGaD
Cyclosporine—Insomnia—Prednisone—atopic dermatitis	1.73e-05	0.000165	CcSEcCtD
Cyclosporine—Paraesthesia—Prednisone—atopic dermatitis	1.72e-05	0.000164	CcSEcCtD
Cyclosporine—PPIA—Disease—CCR5—atopic dermatitis	1.71e-05	0.000568	CbGpPWpGaD
Cyclosporine—Pruritus—Triamcinolone—atopic dermatitis	1.71e-05	0.000163	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—IL18—atopic dermatitis	1.71e-05	0.000568	CbGpPWpGaD
Cyclosporine—Pruritus—Methylprednisolone—atopic dermatitis	1.71e-05	0.000163	CcSEcCtD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.7e-05	0.000566	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ADSL—atopic dermatitis	1.7e-05	0.000564	CbGpPWpGaD
Cyclosporine—Dizziness—Hydrocortisone—atopic dermatitis	1.7e-05	0.000162	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CCR5—atopic dermatitis	1.69e-05	0.00056	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD8A—atopic dermatitis	1.69e-05	0.000559	CbGpPWpGaD
Cyclosporine—Dyspepsia—Prednisone—atopic dermatitis	1.68e-05	0.000161	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—CD4—atopic dermatitis	1.66e-05	0.000552	CbGpPWpGaD
Cyclosporine—Decreased appetite—Prednisone—atopic dermatitis	1.66e-05	0.000159	CcSEcCtD
Cyclosporine—ABCC1—Disease—GLB1—atopic dermatitis	1.66e-05	0.000551	CbGpPWpGaD
Cyclosporine—Rash—Prednisolone—atopic dermatitis	1.66e-05	0.000158	CcSEcCtD
Cyclosporine—Dermatitis—Prednisolone—atopic dermatitis	1.66e-05	0.000158	CcSEcCtD
Cyclosporine—Diarrhoea—Methylprednisolone—atopic dermatitis	1.65e-05	0.000158	CcSEcCtD
Cyclosporine—Fatigue—Prednisone—atopic dermatitis	1.65e-05	0.000157	CcSEcCtD
Cyclosporine—Headache—Prednisolone—atopic dermatitis	1.65e-05	0.000157	CcSEcCtD
Cyclosporine—Constipation—Prednisone—atopic dermatitis	1.63e-05	0.000156	CcSEcCtD
Cyclosporine—Vomiting—Hydrocortisone—atopic dermatitis	1.63e-05	0.000156	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—STAT6—atopic dermatitis	1.63e-05	0.00054	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TAC1—atopic dermatitis	1.62e-05	0.000538	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NPS—atopic dermatitis	1.62e-05	0.000538	CbGpPWpGaD
Cyclosporine—Rash—Hydrocortisone—atopic dermatitis	1.62e-05	0.000155	CcSEcCtD
Cyclosporine—Dermatitis—Hydrocortisone—atopic dermatitis	1.62e-05	0.000155	CcSEcCtD
Cyclosporine—Headache—Hydrocortisone—atopic dermatitis	1.61e-05	0.000154	CcSEcCtD
Cyclosporine—Dizziness—Triamcinolone—atopic dermatitis	1.6e-05	0.000153	CcSEcCtD
Cyclosporine—Dizziness—Methylprednisolone—atopic dermatitis	1.6e-05	0.000152	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—CXCR3—atopic dermatitis	1.59e-05	0.000528	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	1.59e-05	0.000526	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—PPARA—atopic dermatitis	1.58e-05	0.000525	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Prednisone—atopic dermatitis	1.58e-05	0.00015	CcSEcCtD
Cyclosporine—Asthenia—Betamethasone—atopic dermatitis	1.57e-05	0.00015	CcSEcCtD
Cyclosporine—Asthenia—Dexamethasone—atopic dermatitis	1.57e-05	0.00015	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Prednisone—atopic dermatitis	1.56e-05	0.000149	CcSEcCtD
Cyclosporine—Nausea—Prednisolone—atopic dermatitis	1.56e-05	0.000149	CcSEcCtD
Cyclosporine—Pruritus—Dexamethasone—atopic dermatitis	1.55e-05	0.000148	CcSEcCtD
Cyclosporine—Pruritus—Betamethasone—atopic dermatitis	1.55e-05	0.000148	CcSEcCtD
Cyclosporine—SLCO1A2—Metabolism—GLB1—atopic dermatitis	1.54e-05	0.000513	CbGpPWpGaD
Cyclosporine—Vomiting—Triamcinolone—atopic dermatitis	1.54e-05	0.000147	CcSEcCtD
Cyclosporine—Vomiting—Methylprednisolone—atopic dermatitis	1.53e-05	0.000147	CcSEcCtD
Cyclosporine—Nausea—Hydrocortisone—atopic dermatitis	1.53e-05	0.000146	CcSEcCtD
Cyclosporine—Rash—Triamcinolone—atopic dermatitis	1.53e-05	0.000146	CcSEcCtD
Cyclosporine—Dermatitis—Triamcinolone—atopic dermatitis	1.52e-05	0.000146	CcSEcCtD
Cyclosporine—Rash—Methylprednisolone—atopic dermatitis	1.52e-05	0.000145	CcSEcCtD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.52e-05	0.000505	CbGpPWpGaD
Cyclosporine—Dermatitis—Methylprednisolone—atopic dermatitis	1.52e-05	0.000145	CcSEcCtD
Cyclosporine—Urticaria—Prednisone—atopic dermatitis	1.52e-05	0.000145	CcSEcCtD
Cyclosporine—Headache—Triamcinolone—atopic dermatitis	1.52e-05	0.000145	CcSEcCtD
Cyclosporine—Headache—Methylprednisolone—atopic dermatitis	1.51e-05	0.000144	CcSEcCtD
Cyclosporine—Abdominal pain—Prednisone—atopic dermatitis	1.51e-05	0.000144	CcSEcCtD
Cyclosporine—Body temperature increased—Prednisone—atopic dermatitis	1.51e-05	0.000144	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—IL5—atopic dermatitis	1.51e-05	0.0005	CbGpPWpGaD
Cyclosporine—Diarrhoea—Betamethasone—atopic dermatitis	1.5e-05	0.000143	CcSEcCtD
Cyclosporine—Diarrhoea—Dexamethasone—atopic dermatitis	1.5e-05	0.000143	CcSEcCtD
Cyclosporine—SLCO1A2—Metabolism—ADSL—atopic dermatitis	1.48e-05	0.000491	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	1.47e-05	0.000489	CbGpPWpGaD
Cyclosporine—Dizziness—Dexamethasone—atopic dermatitis	1.45e-05	0.000139	CcSEcCtD
Cyclosporine—Dizziness—Betamethasone—atopic dermatitis	1.45e-05	0.000139	CcSEcCtD
Cyclosporine—Nausea—Triamcinolone—atopic dermatitis	1.44e-05	0.000137	CcSEcCtD
Cyclosporine—Nausea—Methylprednisolone—atopic dermatitis	1.43e-05	0.000137	CcSEcCtD
Cyclosporine—PPP3CA—Disease—CCR5—atopic dermatitis	1.42e-05	0.000472	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.41e-05	0.000469	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCR3—atopic dermatitis	1.41e-05	0.000468	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.41e-05	0.000468	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Prednisone—atopic dermatitis	1.41e-05	0.000135	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—MAPK8—atopic dermatitis	1.41e-05	0.000467	CbGpPWpGaD
Cyclosporine—Vomiting—Betamethasone—atopic dermatitis	1.4e-05	0.000133	CcSEcCtD
Cyclosporine—Vomiting—Dexamethasone—atopic dermatitis	1.4e-05	0.000133	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.39e-05	0.000463	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GLB1—atopic dermatitis	1.39e-05	0.000461	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.39e-05	0.00046	CbGpPWpGaD
Cyclosporine—Rash—Dexamethasone—atopic dermatitis	1.38e-05	0.000132	CcSEcCtD
Cyclosporine—Rash—Betamethasone—atopic dermatitis	1.38e-05	0.000132	CcSEcCtD
Cyclosporine—Dermatitis—Dexamethasone—atopic dermatitis	1.38e-05	0.000132	CcSEcCtD
Cyclosporine—Dermatitis—Betamethasone—atopic dermatitis	1.38e-05	0.000132	CcSEcCtD
Cyclosporine—Headache—Dexamethasone—atopic dermatitis	1.38e-05	0.000131	CcSEcCtD
Cyclosporine—Headache—Betamethasone—atopic dermatitis	1.38e-05	0.000131	CcSEcCtD
Cyclosporine—Asthenia—Prednisone—atopic dermatitis	1.37e-05	0.000131	CcSEcCtD
Cyclosporine—Pruritus—Prednisone—atopic dermatitis	1.35e-05	0.000129	CcSEcCtD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.35e-05	0.000447	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ADSL—atopic dermatitis	1.33e-05	0.000442	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GLB1—atopic dermatitis	1.32e-05	0.000438	CbGpPWpGaD
Cyclosporine—Diarrhoea—Prednisone—atopic dermatitis	1.31e-05	0.000125	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—NFKBIA—atopic dermatitis	1.31e-05	0.000434	CbGpPWpGaD
Cyclosporine—Nausea—Betamethasone—atopic dermatitis	1.3e-05	0.000125	CcSEcCtD
Cyclosporine—Nausea—Dexamethasone—atopic dermatitis	1.3e-05	0.000125	CcSEcCtD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.29e-05	0.000429	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CXCL10—atopic dermatitis	1.29e-05	0.000427	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ADSL—atopic dermatitis	1.27e-05	0.00042	CbGpPWpGaD
Cyclosporine—Dizziness—Prednisone—atopic dermatitis	1.26e-05	0.000121	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—TAC1—atopic dermatitis	1.26e-05	0.000417	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NPS—atopic dermatitis	1.26e-05	0.000417	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCR3—atopic dermatitis	1.23e-05	0.000409	CbGpPWpGaD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.23e-05	0.000408	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GLB1—atopic dermatitis	1.22e-05	0.000406	CbGpPWpGaD
Cyclosporine—Vomiting—Prednisone—atopic dermatitis	1.22e-05	0.000116	CcSEcCtD
Cyclosporine—CYP3A7—Metabolism—GLB1—atopic dermatitis	1.21e-05	0.000402	CbGpPWpGaD
Cyclosporine—Rash—Prednisone—atopic dermatitis	1.21e-05	0.000115	CcSEcCtD
Cyclosporine—Dermatitis—Prednisone—atopic dermatitis	1.2e-05	0.000115	CcSEcCtD
Cyclosporine—Headache—Prednisone—atopic dermatitis	1.2e-05	0.000114	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—CASP8—atopic dermatitis	1.18e-05	0.000391	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ADSL—atopic dermatitis	1.17e-05	0.000389	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL5—atopic dermatitis	1.17e-05	0.000388	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ADSL—atopic dermatitis	1.16e-05	0.000386	CbGpPWpGaD
Cyclosporine—Nausea—Prednisone—atopic dermatitis	1.14e-05	0.000108	CcSEcCtD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.13e-05	0.000373	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SLC11A1—atopic dermatitis	1.11e-05	0.000369	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL5—atopic dermatitis	1.11e-05	0.000367	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CCR5—atopic dermatitis	1.1e-05	0.000366	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CD4—atopic dermatitis	1.08e-05	0.000357	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.07e-05	0.000355	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	1.03e-05	0.000341	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NGF—atopic dermatitis	1.02e-05	0.00034	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.02e-05	0.000339	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CXCL8—atopic dermatitis	1.02e-05	0.000339	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PPARA—atopic dermatitis	1.02e-05	0.000338	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.01e-05	0.000336	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.01e-05	0.000334	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IFNG—atopic dermatitis	1e-05	0.000333	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCR5—atopic dermatitis	9.97e-06	0.000331	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL10—atopic dermatitis	9.97e-06	0.000331	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL2—atopic dermatitis	9.75e-06	0.000324	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.74e-06	0.000323	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD4—atopic dermatitis	9.68e-06	0.000321	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.63e-06	0.00032	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.63e-06	0.000319	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	9.46e-06	0.000314	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	9.2e-06	0.000305	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.15e-06	0.000304	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—IL6—atopic dermatitis	8.99e-06	0.000298	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL1B—atopic dermatitis	8.94e-06	0.000297	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CD4—atopic dermatitis	8.94e-06	0.000297	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL2—atopic dermatitis	8.91e-06	0.000296	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GLB1—atopic dermatitis	8.76e-06	0.000291	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL5—atopic dermatitis	8.58e-06	0.000285	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	8.47e-06	0.000281	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NFKBIA—atopic dermatitis	8.45e-06	0.00028	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ADSL—atopic dermatitis	8.4e-06	0.000279	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—MAPK8—atopic dermatitis	8.2e-06	0.000272	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NGF—atopic dermatitis	7.95e-06	0.000264	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCR5—atopic dermatitis	7.73e-06	0.000256	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GLB1—atopic dermatitis	7.59e-06	0.000252	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ADSL—atopic dermatitis	7.28e-06	0.000241	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CD4—atopic dermatitis	6.93e-06	0.00023	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GLB1—atopic dermatitis	6.77e-06	0.000225	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GLB1—atopic dermatitis	6.61e-06	0.000219	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NFKBIA—atopic dermatitis	6.55e-06	0.000217	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ADSL—atopic dermatitis	6.49e-06	0.000216	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	6.4e-06	0.000212	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ADSL—atopic dermatitis	6.34e-06	0.00021	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GLB1—atopic dermatitis	6.23e-06	0.000207	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GLB1—atopic dermatitis	6.18e-06	0.000205	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CXCL8—atopic dermatitis	6.03e-06	0.0002	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PPARA—atopic dermatitis	6e-06	0.000199	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ADSL—atopic dermatitis	5.97e-06	0.000198	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ADSL—atopic dermatitis	5.92e-06	0.000197	CbGpPWpGaD
Cyclosporine—PPIA—Disease—IL6—atopic dermatitis	5.82e-06	0.000193	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL2—atopic dermatitis	5.76e-06	0.000191	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PPARA—atopic dermatitis	5.76e-06	0.000191	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL6—atopic dermatitis	5.73e-06	0.00019	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CCR5—atopic dermatitis	5.62e-06	0.000186	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.53e-06	0.000184	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MAPK8—atopic dermatitis	5.3e-06	0.000176	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL6—atopic dermatitis	5.24e-06	0.000174	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.07e-06	0.000168	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PPARA—atopic dermatitis	5.01e-06	0.000166	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.94e-06	0.000164	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—IL6—atopic dermatitis	4.83e-06	0.00016	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL8—atopic dermatitis	4.67e-06	0.000155	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.58e-06	0.000152	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PPARA—atopic dermatitis	4.51e-06	0.00015	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.5e-06	0.000149	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—atopic dermatitis	4.47e-06	0.000148	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PPARA—atopic dermatitis	4.29e-06	0.000142	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK8—atopic dermatitis	4.11e-06	0.000136	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GLB1—atopic dermatitis	4.07e-06	0.000135	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARA—atopic dermatitis	3.97e-06	0.000132	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARA—atopic dermatitis	3.93e-06	0.000131	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.91e-06	0.00013	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—IL6—atopic dermatitis	3.75e-06	0.000124	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—atopic dermatitis	3.53e-06	0.000117	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—atopic dermatitis	3.39e-06	0.000112	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARA—atopic dermatitis	2.84e-06	9.44e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—atopic dermatitis	2.63e-06	8.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARA—atopic dermatitis	2.46e-06	8.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARA—atopic dermatitis	2.2e-06	7.3e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARA—atopic dermatitis	2.15e-06	7.12e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.02e-06	6.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARA—atopic dermatitis	2e-06	6.65e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—atopic dermatitis	1.91e-06	6.33e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.32e-06	4.39e-05	CbGpPWpGaD
